Corbus Pharmaceuticals Holdings, Inc. (CRBP) News

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Today's Latest Price: $1.22 USD

0.00 (0.00%)

Updated Nov 24 6:55pm

Add CRBP to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 389 in Biotech

See all "A" rated Strong Buy stocks

Filter CRBP News Items

CRBP News Results

Event/Time Symbol Company News Detail Start End Change POWR Rating
Loading, please wait...

Latest CRBP News From Around the Web

Below are the latest news stories about Corbus Pharmaceuticals Holdings Inc that investors may wish to consider to help them evaluate CRBP as an investment opportunity.

Cannabis Stock Gainers And Losers From September 29, 2020

GAINERS: 48North Cannabis (PINK: NCNNF ) shares closed up 27.27% at $0.14 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 20.12% at $1.97 GrowGeneration (NASDAQ: GRWG ) shares closed up 9.13% at $16.02 Aleafia Health (OTCQX: ALEAF ) shares closed up 7.71% at $0.37 CV Sciences (OTCQB: CVSI ) shares closed up 7.57% at $0.54 Marrone Bio Innovations (NASDAQ: MBII ) shares closed up 6.78% at $1.26 Item 9 Labs (OTCQX: INLB ) shares closed up 1.33% at $6.4 BioHarvest Sciences (OTC: CNVCF) shares closed up … Full story available on

Benzinga | September 29, 2020

Cannabis Stock Gainers And Losers From September 9, 2020

Gainers: AusCann Group Holdings (OTC: ACNNF ) shares closed up 24.11% at $0.12 Heritage Cannabis Holding (OTC: HERTF ) shares closed up 18.04% at $0.08 NexTech AR Solns (OTC: NEXCF ) shares closed up 13.42% at $4.09 Cann Gr (OTC: CNGGF ) shares closed up 10.34% at $0.32 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 9.42% at $2.44 Emerald Health (OTC: EMHTF ) shares closed up 8.74% at $0.17 Bloom Energy (NYSE: BE ) … Full story available on

Benzinga | September 9, 2020

The Daily Biotech Pulse: AstraZeneca Pauses Coronavirus Vaccine Study, Trillium To Get $25M Pfizer Investment

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Akouos Inc (NASDAQ: AKUS ) Albireo Pharma Inc (NASDAQ: ALB )(announced positive Phase 3 results for odevixibat in a liver disorder called progressive familial intrahepatic cholestasis) Castle Biosciences Inc (NASDAQ: CSTL ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Kura Oncology Inc (NASDAQ: KURA ) Merit Medical Systems, Inc. (NASDAQ: MMSI )(announced sale of manufacturing equipment and associated assets used in its hypotube manufacturing business) X T L Biopharmaceuticals Ltd (NASDAQ: XTLB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 8) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AEterna Zentaris Inc. (NASDAQ: AEZS )(announced the presentation of data from pediatric study of macimorelin for childhood-o...

Benzinga | September 9, 2020

Why Corbus Pharma Shares Are Sinking

Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) shares were plummeting hard Tuesday following an adverse clinical data readout. What Happened: Top-line …

Benzinga | September 8, 2020

The Daily Biotech Pulse: Liver Congress Underway, FDA Approves Companion Diagnostic Test For Clovis Cancer Drug, EUA For Abbott's $5, 15-Minute COVID-19 Test

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) 10X Genomics Inc (NASDAQ: TXG ) Abbott Laboratories (NYSE: ABT ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) Fluidigm Corporation (NASDAQ: FLDM ) ( announced emergency use authorization for its saliva-based COVID-19 test) Generation Bio Co (NASDAQ: GBIO ) Inari Medical Inc (NASDAQ: NARI ) Kura Oncology Inc (NASDAQ: KURA ) Lantern Pharma Inc. (NASDAQ: LTRN ) Ocular Therapeutix Inc (NASDAQ: OCUL ) PPD Inc (NASDAQ: PPD ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) Revance Therapeutics Inc (NASDAQ: RVNC ) Silk Road Medical Inc (NASDAQ: SILK ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Aug. 26) Odonate Therapeutics Inc (NASDAQ: ODT ) Polypid Ltd (NASDAQ: PYPD ) Stocks In Focus FDA Approves Companion Diagnos...

Benzinga | August 27, 2020

Corbus Pharmaceuticals: Ultra High Implied Volatility Brings Opportunity

Implied volatility in the September cycle in Corbus Pharmaceuticals (CRBP) is almost trading at 350% as we can see from the chart below. Why is this significant for us as traders and investors who constantly scour the market for opportunity? Well, remember implied volatility is basically a read on where...

Individual Trader on Seeking Alpha | August 21, 2020

Cannabis Stock Gainers And Losers From August 20, 2020

Gainers: MGC Pharmaceuticals (OTC: MGCLF ) shares closed up 68.6% at $0.03 Zelira Therapeutics (OTC: ZLDAF ) shares closed up 15.79% at $0.04 Zenabis Global (OTC: ZBISF ) shares closed up 10.14% at $0.08 Next Green Wave Holdings (OTC: NXGWF ) shares closed up 8.46% at $0.17 SOL Global Investments (OTC: SOLCF ) shares closed up 8.86% at $0.35 Canopy Rivers (OTC: CNPOF ) shares closed up 8.06% at $0.67 Halo Labs (OTC: AGEEF ) shares closed up 6.65% at $0.093 Corbus Pharmaceuticals (NASDAQ: CRBP ) shares closed up 5.45% at $8.13 cbdMd, Inc. (AMEX: YCBD) shares closed up 5.42% at $2.92 Icanic Brands (OTC: Full story available on

Benzinga | August 20, 2020

Thinking about trading options or stock in Qualcomm, Yandex, Advanced Micro Devices, Estee Lauder, or Corbus Pharmaceuticals?

NEW YORK, Aug. 13, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for QCOM, YNDX, AMD, EL, and CRBP. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different…

PR Newswire | August 13, 2020

Corbus Pharmaceuticals EPS misses by $0.14, misses on revenue

Corbus Pharmaceuticals (CRBP): Q2 GAAP EPS of -$0.52 misses by $0.14.Revenue of $0.3M (-99.0% Y/Y) misses by $3.09M.Press Release...

Seeking Alpha | August 6, 2020

Corbus Pharmaceuticals to Report Second Quarter Results on August 6, 2020

* Management to host conference call and webcast on Thursday, August 6 at 8:30 a.m. ETNorwood, MA, July 30, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid system, today announced that it will report its second quarter financial results on Thursday, August 6. Corbus management will host a conference call and live audio webcast to discuss operational and financial results at 8:30 a.m. ET that same day.The call will be led by Yuval Cohen, Ph.D., Chief Executive Officer of Corbus. He will be joined by additional members of the Corbus management team. Interested participants and investors may access the conference call by di...

Yahoo | July 30, 2020

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.1926 seconds.